[Behavior of the serum concentration of pregnancy associated alpha 2 glycoprotein (alpha 2-PAG) in gynecologic carcinomas (author's transl)].
The serum concentration of Alpha 2-PAG was measured in a group of women (n = 204) with different sites and types of gynecological carcinomas and various stages. In a follow-up study over a period of 2 years a positive correlation between Alpha 2-PAG serum concentration and clinical course was found in 50 of 139 woman (35.9%) only. These results suggest that Alpha 2-PAG is an unsatisfactory marker in a majority of the gynecological malignomas studied.
D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood*; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood; D011257:Pregnancy Proteins / Q000032:analysis*; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000097:blood; D014594:Uterine Neoplasms / Q000097:blood; D014846:Vulvar Neoplasms / Q000097:blood
D011257:Pregnancy Proteins
Das Verhalten der Serumkonzentration des schwangerschaftsassoziierten alpha 2-Glykoproteins (Alpha 2-PAG) bei gynäkologischen Karzinomen.